Abstract:Pulmonary arterial hypertension (PAH) is a progressive pulmonary vascular disease associated with dysfunction of pulmonary artery endothelial cells and pulmonary artery smooth muscle cells (PASMCs). To explore the potential mechanism of miR-193-3p in pulmonary arterial hypertension, human PASMCs and rats were respectively stimulated by hypoxia and monocrotaline to establish PAH model in vivo and in vitro. The expressions of miR-193-3p and p21-activated protein kinase 4 (PAK4) in the lung samples of PAH patients and paired healthy samples from the healthy subjects in PHA cells and rats were detected by quantitative reverse transcriptase-PCR. Morphological changes in lung tissues were determined using hematoxylin and eosin staining. Right ventricular systolic pressure (RVSP) and ratio of right ventricle to left ventricle plus septum (RV/LV p S) were measured. The binding relationship between miR-193-3p and PAK4 was analyzed by TargetScan and verified by luciferase reporter assay. Cell viability, apoptosis, and migration were detected by 3-(4, 5-Dimethylthiazol-2- yl)-2,5-diphenyltetrazolium bromide (MTT) flow cytometry, and wound-healing assays, respectively. The protein expressions of PAK4, proliferating cell nuclear antigen (PCNA), P21, p-AKT, and AKT in vivo or in vitro were determined by Western blot. In this study, we found that in pulmonary arterial hypertension, miR-193-3p expression was downregulated and PAK4 expression was up-regulated. MiR-193-3p directly targeted PAK4 and negatively regulated its expression. Hypoxia condition promoted cell proliferation, migration, and inhibited apoptosis accompanied with increased expressions of PCNA and p-AKT/AKT and decreased expression of P21 in PASMCs. MiR-193-3p overexpression attenuated the effects of hypoxia on PASMCs via downregulating PAK4. Monocrotaline treatment increased p-AKT/AKT and decreased P21 expression and caused pulmonary vascular remodeling in the model rats. MiR-193-3p overexpression attenuated pulmonary vascular remodeling, decreased p-AKT/AKT, and increased P21 levels via downregulating PAK4 in monocrotaline-induced rats. The results in this study demonstrated that upregulation of miR-193-3p reduced cell proliferation, migration, and apoptosis of PAH in vitro and pulmonary vascular remodeling in PAH in vivo through downregulating PAK4.

miR‐30d Attenuates Pulmonary Arterial Hypertension via Targeting MTDH and PDE5A and Modulates the Beneficial Effect of Sildenafil

MicroRNA-663 Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension by Targeting TGF-β1/smad2/3 Signaling

Sildenefil Increases Connexin 40 in Smooth Muscle Cells Through Activation of BMP Pathways in Pulmonary Arterial Hypertension.

Abstract 12535: MicroRNA-663 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension by Targeting TGFβ1/smad2/3 Signaling

MicroRNA-223 Attenuates Hypoxia-induced Vascular Remodeling by Targeting RhoB/MLC2 in Pulmonary Arterial Smooth Muscle Cells

MicroRNA‐483 Amelioration of Experimental Pulmonary Hypertension

MiR-193-3p Attenuates the Vascular Remodeling in Pulmonary Arterial Hypertension by Targeting PAK4

MicroRNA‐140‐5p Targeting Tumor Necrosis Factor‐α Prevents Pulmonary Arterial Hypertension

microRNA-637/661 ameliorate hypoxic-induced pulmonary arterial hypertension by targeting TRIM29 signaling pathway

Human pulmonary artery smooth muscle cell dysfunction is regulated by miR-509-5p in hypoxic environment

MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension

Inhibition of Mir-4640-5p Alleviates Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease Patients by Regulating Nitric Oxide Synthase 1

MiR-125a-5p Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension by Targeting the TGF-β1 and IL-6/STAT3 Signaling Pathways

MicroRNA-150 Attenuates Hypoxia-Induced Excessive Proliferation and Migration of Pulmonary Arterial Smooth Muscle Cells Through Reducing HIF-1α Expression

MicroRNA-221 Promotes Proliferation and Migration of Pulmonary Arterial Smooth Muscle Cells (pasmcs) by Targeting Tissue Inhibitor of Metalloproteinases-3 (TIMP3).

Mir-145: A Role in the Development of Pulmonary Arterial Hypertension

Effect of miR-29b on the Proliferation and Apoptosis of Pulmonary Artery Smooth Muscle Cells by Targeting Mcl-1 and CCND2

MicroRNA-27b plays a role in pulmonary arterial hypertension by modulating peroxisome proliferator-activated receptor γ dependent Hsp90-eNOS signaling and nitric oxide production.

MFN2-dependent Mitochondrial Dysfunction Contributes to Relm-(3-induced Pulmonary Arterial Hypertension Via USP18/Twist1/miR-214 Pathway

MiR-449a-5p mediates mitochondrial dysfunction and phenotypic transition by targeting Myc in pulmonary arterial smooth muscle cells

FGF21 attenuates pulmonary arterial hypertension via downregulation of miR‐130, which targets PPARγ